QuickView for Suppressor of forked (biogroup)

1. Resistance to RNA-directed nucleoside analogues in B-Cell neoplasms
2. L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
3. L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
4. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
5. L1000 CMAP - Fibrocystic disease of breast MCF10A cells treated with ligand perturbagens

There were no matches for Suppressor of forked

1. FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
2. A Phase 1/2 Trial of SRA737 in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in S…
3. Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By S…
4. Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or…